No Time for Delay

Research continues to uncover the impact of the COVID-19 pandemic on cancer diagnosis and treatment. The findings are troubling. Across all age groups there was a substantial decrease in cancer pathology reports in 2020 as compared to 2019. The age group that saw the steepest decline (38%) in biopsies and testing was under 18 years old.

In order to avoid compounding the physical and emotional challenges of delayed cancer diagnosis and treatment, medical care teams move with absolute efficiency when delivering care to patients. Treatment plans take into consideration that precious time has been lost; therapies prescribed are precise and robust.

As we begin to heal from the COVID pandemic, it is more important than ever that the personalized treatment plans physicians craft to meet the unique needs of each patient are not obstructed due to bureaucratic utilization management policies such as prior authorization and fail first/step therapy. Patients and Providers United amplifies the voices that seek to keep patients and providers – not middlemen driven by cost containment goals – at the center of medical decision making.